Biopsy, Ureter
Neoplasms involving ureter are rare but recent advancements in our understanding has begun to change the clinical management of these lesions. Radical nephroureterectomy, which used to be the gold standard treatment for upper tract urothelial carcinoma (UTUC) carries a significant surgical risk apart from loss of a functioning kidney (even when not involved). Biopsy of the ureter helps select patients for nephron-sparing endoscopic treatment which provides excellent outcome, particularly when the disease is low-grade.
Ureteric biopsies are largely obtained through an endoscopic approach. Although percutaneous biopsy is described in the literature, it is not widely practiced. Ureteroscopic visualization of the lesion allows better sampling, qualitatively and quantitatively. After appropriate patient preparation, an ureteroscope is used to directly visualize the urinary tract to identify the lesion. Multiple urine samples from different anatomic sites are obtained for cytologic examination. A biopsy forceps or a flat wire basket is used to sample the lesion. The procedure can be performed under local anesthesia and is generally well-tolerated with minimal patient discomfort. Some patients experience transient gross hematuria which can managed conservatively. Post-operative infections, ureteral perforation and ureteral strictures are rare complications.
There are no universal reference ranges for ureter biopsy specimens. In general, a normal biopsy sample consists of benign urothelial epithelium with underlying fibrovascular connective tissue stroma.
Biopsy specimens are placed directly in formalin fixative. Cytology samples need to be placed in fixative solutions provided by the laboratory and vary depending on the commercial platforms used by the laboratory.
- J Endourol. 2013 Dec;27(12):1450-4. [PMID: 24251426]
- Arch Pathol Lab Med. 2013 Mar;137(3):400-7. [PMID: 23451751]
- Int J Urol. 2003 Dec;10(12):627-30. [PMID: 14633064]
- J Urol. 1997 Jan;157(1):33-7. [PMID: 8976209]